ACIPHEX SPRINKLE Drug Patent Profile
✉ Email this page to a colleague
When do Aciphex Sprinkle patents expire, and what generic alternatives are available?
Aciphex Sprinkle is a drug marketed by Aytu and is included in one NDA.
The generic ingredient in ACIPHEX SPRINKLE is rabeprazole sodium. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the rabeprazole sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aciphex Sprinkle
A generic version of ACIPHEX SPRINKLE was approved as rabeprazole sodium by CHARTWELL RX on November 8th, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACIPHEX SPRINKLE?
- What are the global sales for ACIPHEX SPRINKLE?
- What is Average Wholesale Price for ACIPHEX SPRINKLE?
Summary for ACIPHEX SPRINKLE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Patent Applications: | 1,140 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ACIPHEX SPRINKLE |
DailyMed Link: | ACIPHEX SPRINKLE at DailyMed |
![ACIPHEX SPRINKLE drug patent expirations Drug patent expirations by year for ACIPHEX SPRINKLE](/p/graph/s/t/ACIPHEX_SPRINKLE-patent-expirations.png)
![Drug Prices for ACIPHEX SPRINKLE](/p/graph/drug-price/ACIPHEX+SPRINKLE.png)
US Patents and Regulatory Information for ACIPHEX SPRINKLE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aytu | ACIPHEX SPRINKLE | rabeprazole sodium | CAPSULE, DELAYED RELEASE;ORAL | 204736-001 | Mar 26, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aytu | ACIPHEX SPRINKLE | rabeprazole sodium | CAPSULE, DELAYED RELEASE;ORAL | 204736-002 | Mar 26, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACIPHEX SPRINKLE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aytu | ACIPHEX SPRINKLE | rabeprazole sodium | CAPSULE, DELAYED RELEASE;ORAL | 204736-001 | Mar 26, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Aytu | ACIPHEX SPRINKLE | rabeprazole sodium | CAPSULE, DELAYED RELEASE;ORAL | 204736-002 | Mar 26, 2013 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ACIPHEX SPRINKLE
See the table below for patents covering ACIPHEX SPRINKLE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0786461 | ⤷ Sign Up | |
Denmark | 174366 | ⤷ Sign Up | |
Hong Kong | 194296 | Pyridine derivatives pharmaceutical compositions comprising the same the use of the same for the manufacture of medicaments having therapeutic or preventative value and a process for preparing the same | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ACIPHEX SPRINKLE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0268956 | C990015 | Netherlands | ⤷ Sign Up | PRODUCT NAME: RABEPRAZOLI, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER RABEPRAZOLI NATRICUM; NATL REGISTRATION NO/DATE: RVG 23210-11 19981208; FIRST REGISTRATION: GB 10555/0008 AND 10555/0010 19980508 |
0268956 | 1999C0030 | Belgium | ⤷ Sign Up | PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508 |
0268956 | SPC/GB98/040 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |